Screening for ATM sequence alterations in African-American women diagnosed with breast cancer

Breast Cancer Research and Treatment

Volumn 107, Issue 1, 2008, Pages 139-144

  Hirsch, Ariel E ^a,c,d   Atencio, David P ^b   Rosenstein, Barry S ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

African American women; ATM; Breast cancer

Indexed keywords

ATM PROTEIN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONTROL GROUP; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GROUPS BY AGE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL;

AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MASS SCREENING; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 36549032069     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9531-x     Document Type: Article

References (45)

1. Phillips K-A, Glendon G, Knight J (1999) Putting the risk of breast cancer in perspective. N Engl J Med 340:141-144
2. Thull DL, Vogel VG (2004) Recognition and management of hereditary breast cancer syndromes. Oncologist 9:13-24
3. Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1. BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388
4. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646
5. Malone KE, Daling JR, Neal C et al (2000) Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88:1393-1402
6. Nelen MR Padberg GW, Peeters EA et al (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13:114-116
7. Nelen MR, Padberg GW, Peeters EA et al (2004) CHEK2*1100 delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175-1182
8. Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100 delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55-59
9. McKinnon PJ (2004) ATM and ataxia telangiectasia. EMBO Rep, 5:772-776
10. Lavin MF (2005) How important is ATM? Radiat Res 163:704
11. Morrell D Cromartie E Swift M (1986) Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst 77:89-92
12. Swift M, Morrell D, Massey PB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836
13. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155-168
14. De Jong MM, Nolte IM, te Meerman GJ et al (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225-242
15. Inskip HM, Kinlen LJ, Taylor AM, Woods CG, Arlett CF (1999) Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer 79:1304-1307
16. Geoffroy-Perez B, Janin N, Ossian V et al (2001) Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 93:288-293
17. Olsen JH, Hahnemann JM, Borresen-Dale AL et al (2001) Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst 93:121-127
18. Renwick A, Thompson D, Seal S et al (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38:873-875
19. Angele S, Romestaing P, Moullan N et al (2003) ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63:8717-8725
20. Szabo CI, Schutte M, Broeks A et al (2004) Are ATM mutations 7271T→G and IVS10-6T→G really high-risk breast cancer-susceptibility alleles? Cancer Res 64:840-843
21. Thompson D, Duedal S, Kirner J et al (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97:813-822
22. Stredrick DL, Garcia-Closas M, Pineda MA et al (2006) The ATM missense mutation p.Ser49Cys (c.146C > G) and the risk of breast cancer. Hum Mutat 27:538-544
23. Heikkinen K, Rapakko K, Karppinen SM et al (2005) Association of common ATM polymorphism with bilateral breast cancer. Int J Cancer 116:69-72
24. Langholz B, Bernstein JL, Bernstein L et al (2006) On the proposed association of the ATM variants 5557G > A and IVS38-8T > C and bilateral breast cancer. Int J Cancer 119:724-725
25. Koren M, Kimmel G, Ben-Asher E et al (2006) ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer 94:1537-1543
26. Bernstein JL, Bernstein L, Thompson WD et al (2003) ATM variants 7271T > G and IVS10-6T > G among women with unilateral and bilateral breast cancer. Br J Cancer 89:1513-1516
27. Lindeman GJ, Hiew M, Visvader JE et al (2004) Frequency of the ATM IVS10-6T→G variant in Australian multiple-case breast cancer families. Breast Cancer Res 6:R401-R407
28. Sommer SS, Buzin CH, Jung M et al (2002) Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls. Cancer Genet Cytogenet 134:25-32
29. Sommer SS, Jiang Z, Feng J et al (2003) ATM missense mutations are frequent in patients with breast cancer. Cancer Genet Cytogenet 145:115-120
30. Bretsky P, Haiman CA, Gilad S et al (2003) The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. Cancer Epidemiol Biomarkers Prev 12:733-738
31. Feng J, Yan J, Chen J et al (2003) Absence of somatic ATM missense mutations in 58 mammary carcinomas. Cancer Genet Cytogenet 145:179-182
32. Thorstenson YR, Roxas A, Kroiss R et al (2003) Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res 63:3325-3333
33. Chenevix-Trench G, Spurdle AB, Gatei M et al (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94:205-215
34. Campbell C, Mitui M, Eng L et al (2003) ATM mutations on distinct SNP and STR haplotypes in ataxia-telangiectasia patients of differing ethnicities reveal ancestral founder effects. Hum Mutat 21:80-85
35. Thompson D, Antoniou AC, Jenkins M et al (2005) Two ATM variants and breast cancer risk. Hum Mutat 25:594-595
36. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics 2000, CA. Cancer J Clin 50:7-33
37. Johnson ET (2002) Breast cancer racial differences before age 40-implications for screening. J Natl Med Assoc 94:149-156
38. Pal T, Permuth-Wey J, Holtje T, Sutphen R (2004) BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev 13:1794-1799
39. Elmore JG, Moceri VM, Carter D, Larson EB (1998) Breast carcinoma tumor characteristics in black and white women. Cancer 83:2509-2515
40. Mountain JL, Risch N (2004) Assessing genetic contributions to phenotypic differences among 'racial' and 'ethnic' groups. Nat Genet 36:S48-S53
41. Royal CD, Dunston GM (2004) Changing the paradigm from 'race' to human genome variation. Nat Genet 36:S5-S7
42. Armstrong K, Micco E, Carney A, Stopfer J, Putt M (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. Jama 293:1729-1736
43. Olopade OI, Artioli G (2004) Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast J 10(1):S5-S9
44. Bernstein JL, Langholz B, Haile RW et al (2004) Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study. Breast Cancer Res 6:R199-R214
45. Iannuzzi CM, Atencio DP, Green S, Stock RG, Rosenstein BS (2002) ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52:606-613